Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39


A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia.

Bernardoni R, Giordani G, Signorino E, Monticelli S, Messa F, Pradotto M, Rosso V, Bracco E, Giangrande A, Perini G, Saglio G, Cilloni D.

Haematologica. 2019 Apr;104(4):717-728. doi: 10.3324/haematol.2018.198267. Epub 2018 Nov 8.


Neonatal cholelithiasis in Down syndrome: Is hypothyroidism involved? A case-report.

Ricci F, Stagi S, Messa F, de Martino M.

J Neonatal Perinatal Med. 2018;11(4):423-425. doi: 10.3233/NPM-181.


Towards a sustainable synthesis of amides: chemoselective palladium-catalysed aminocarbonylation of aryl iodides in deep eutectic solvents.

Messa F, Perrone S, Capua M, Tolomeo F, Troisi L, Capriati V, Salomone A.

Chem Commun (Camb). 2018 Jul 17;54(58):8100-8103. doi: 10.1039/c8cc03858a.


A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinoma.

Messa F, Tonissi F, Millo E, Bracco E, Ungari S, Lattanzio L, Merlano M, Damonte G, Lo Nigro C.

Int J Biol Markers. 2014 Mar 24;29(1):e55-61. doi: 10.5301/jbm.5000052.


Novel cAMP binding protein-BP (CREBBP) mutation in a girl with Rubinstein-Taybi syndrome, GH deficiency, Arnold Chiari malformation and pituitary hypoplasia.

Marzuillo P, Grandone A, Coppola R, Cozzolino D, Festa A, Messa F, Luongo C, Del Giudice EM, Perrone L.

BMC Med Genet. 2013 Feb 23;14:28. doi: 10.1186/1471-2350-14-28.


LIN28B polymorphism could modulate the relationship between childhood obesity and age at menarche.

Grandone A, Cirillo G, Messa F, Coppola R, Festa A, Perrone L, del Giudice EM.

J Adolesc Health. 2013 Mar;52(3):375. doi: 10.1016/j.jadohealth.2012.10.273. No abstract available.


Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.

Messa E, Carturan S, Maffè C, Pautasso M, Bracco E, Roetto A, Messa F, Arruga F, Defilippi I, Rosso V, Zanone C, Rotolo A, Greco E, Pellegrino RM, Alberti D, Saglio G, Cilloni D.

Haematologica. 2010 Aug;95(8):1308-16. doi: 10.3324/haematol.2009.016824. Epub 2010 Jun 9.


The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.

Iacobucci I, Lonetti A, Paoloni F, Papayannidis C, Ferrari A, Storlazzi CT, Vignetti M, Cilloni D, Messa F, Guadagnuolo V, Paolini S, Elia L, Messina M, Vitale A, Meloni G, Soverini S, Pane F, Baccarani M, Foà R, Martinelli G.

Haematologica. 2010 Oct;95(10):1683-90. doi: 10.3324/haematol.2009.020792. Epub 2010 Jun 9.


WITHDRAWN: Proteinase 3 (PR3) gene is highly expressed in CBF leukemias and codes for a protein with abnormal nuclear localization that confers drug sensitivity.

Cilloni D, Carturan S, Maffè C, Messa F, Arruga F, Messa E, Pradotto M, Pautasso M, Zanone C, Fornaciari P, Defilippi I, Rotolo A, Greco E, Iacobucci I, Martinelli G, Lo-Coco F, Bracco E, Saglio G.

Leukemia. 2010 Jan 14. [Epub ahead of print]


FOXO transcription factor activity is partially retained in quiescent CML stem cells and induced by tyrosine kinase inhibitors in CML progenitor cells.

Pellicano F, Cilloni D, Helgason GV, Messa F, Panuzzo C, Arruga F, Bracco E, Allan E, Huntly BJ, Holyoake TL, Saglio G.

Blood. 2009 Dec 1. doi: 10.1182/blood-2009-06-226621. Epub 2009 Dec 1. Retraction in: Blood. 2010 Apr 8;115(14):2983.


Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.

Iacobucci I, Lonetti A, Messa F, Ferrari A, Cilloni D, Soverini S, Paoloni F, Arruga F, Ottaviani E, Chiaretti S, Messina M, Vignetti M, Papayannidis C, Vitale A, Pane F, Piccaluga PP, Paolini S, Berton G, Baruzzi A, Saglio G, Baccarani M, Foà R, Martinelli G.

Leukemia. 2010 Jan;24(1):66-73. doi: 10.1038/leu.2009.197. Epub 2009 Sep 17.


Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G.

Blood. 2009 Sep 3;114(10):2159-67. doi: 10.1182/blood-2008-08-173963. Epub 2009 Jul 9. Erratum in: Blood. 2010 Sep 23;116(12):2196.


Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.

Farruggia P, D'Angelo P, Acquaviva A, Trizzino A, Tucci F, Cilloni D, Messa F, D'Ambrosio A, Aricò M.

Pediatr Hematol Oncol. 2009 Apr-May;26(3):129-35. doi: 10.1080/08880010902773024.


Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.

Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini R, Ferrari S, Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP, Soverini S, Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A, Chiaretti S, Müschen M, Foà R, Baccarani M, Martinelli G.

Haematologica. 2008 Dec;93(12):1814-21. doi: 10.3324/haematol.13260. Epub 2008 Oct 6. Erratum in: Haematologica. 2010 Jun;95(6):1033.


Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis.

Messa E, Cilloni D, Messa F, Arruga F, Roetto A, Saglio G.

Acta Haematol. 2008;120(2):70-4. doi: 10.1159/000158631. Epub 2008 Oct 1.


Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignancies.

Nicoli P, Defilippi I, Carturan S, Roetto A, Messa F, Arruga F, Messa E, Rotolo A, Iacobucci I, Bracco E, Saglio G, Cilloni D.

Acta Haematol. 2008;120(1):47-50. doi: 10.1159/000158576. Epub 2008 Sep 30. No abstract available.


Transnasal transesophageal echocardiography: a new approach for the PFO occlusion in awake patients.

Greco C, Chiavari PA, Campolongo G, Mariani S, Messa F, Tallarico D, Schiariti M, Gonnella C, Gaudio C.

Catheter Cardiovasc Interv. 2008 Oct 1;72(4):538-41. doi: 10.1002/ccd.21665.


Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E, Paolini S, Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M, Poerio A, Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S, Perini G, Foà R, Baccarani M, Martinelli G.

Blood. 2008 Nov 1;112(9):3847-55. doi: 10.1182/blood-2007-09-112631. Epub 2008 Jul 23. Erratum in: Blood. 2010 Sep 23;116(12):2196.


Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.

Cilloni D, Messa F, Arruga F, Defilippi I, Gottardi E, Fava M, Carturan S, Catalano R, Bracco E, Messa E, Nicoli P, Diverio D, Sanz MA, Martinelli G, Lo-Coco F, Saglio G.

Haematologica. 2008 Jun;93(6):921-4. doi: 10.3324/haematol.12165. Epub 2008 Apr 28.


Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.

Cilloni D, Messa F, Rosso V, Arruga F, Defilippi I, Carturan S, Catalano R, Pautasso M, Panuzzo C, Nicoli P, Messa E, Morotti A, Iacobucci I, Martinelli G, Bracco E, Saglio G.

Leukemia. 2008 Jun;22(6):1234-40. doi: 10.1038/leu.2008.68. Epub 2008 Apr 10. Retraction in: Leukemia. 2010 May;24(5):1103.


Angiographic evidence of pigmented cardiac paraganglioma.

Gonnella C, Messa FC, Confessore P, Greco C.

J Cardiovasc Med (Hagerstown). 2008 Mar;9(3):319. doi: 10.2459/JCM.0b013e32801411d1. No abstract available.


The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.

Baccarani M, Cilloni D, Rondoni M, Ottaviani E, Messa F, Merante S, Tiribelli M, Buccisano F, Testoni N, Gottardi E, de Vivo A, Giugliano E, Iacobucci I, Paolini S, Soverini S, Rosti G, Rancati F, Astolfi C, Pane F, Saglio G, Martinelli G.

Haematologica. 2007 Sep;92(9):1173-9. Epub 2007 Aug 1.


Nuclear factor kB as a target for new drug development in myeloid malignancies.

Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G.

Haematologica. 2007 Sep;92(9):1224-9. Epub 2007 Aug 1. Review.


WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.

Cilloni D, Messa F, Martinelli G, Gottardi E, Arruga F, Defilippi I, Carturan S, Messa E, Fava M, Giugliano E, Rosso V, Catalano R, Merante S, Nicoli P, Rondoni M, Ottaviani E, Soverini S, Tiribelli M, Pane F, Baccarani M, Saglio G.

Leukemia. 2007 Jul;21(7):1442-50. Epub 2007 May 17.


CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.

Morotti A, Parvis G, Cilloni D, Familiari U, Pautasso M, Bosa M, Messa F, Arruga F, Defilippi I, Catalano R, Rosso V, Carturan S, Bracco E, Guerrasio A, Saglio G.

Leukemia. 2007 Jun;21(6):1305-6. Epub 2007 Mar 22. No abstract available.


Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.

Cilloni D, Messa E, Messa F, Carturan S, Defilippi I, Arruga F, Rosso V, Catalano R, Bracco E, Nicoli P, Saglio G.

Ann N Y Acad Sci. 2006 Nov;1089:411-23. Review.


NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.

Morotti A, Cilloni D, Pautasso M, Messa F, Arruga F, Defilippi I, Carturan S, Catalano R, Rosso V, Chiarenza A, Taulli R, Bracco E, Rege-Cambrin G, Gottardi E, Saglio G.

Am J Hematol. 2006 Dec;81(12):938-45.


Tako-tsubo syndrome: a potential role for cytomegalovirus infection.

Greco C, Saolini M, Mariani S, Santaniello E, Messa F, Tanzilli G, Mangieri E.

J Cardiovasc Med (Hagerstown). 2006 Aug;7(8):623-7.


Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells.

Morotti A, Cilloni D, Messa F, Arruga F, Defilippi I, Carturan S, Catalano R, Rosso V, Chiarenza A, Pilatrino C, Guerrasio A, Taulli R, Bracco E, Pautasso M, Baraban D, Gottardi E, Saglio G.

Cancer. 2006 Mar 1;106(5):1188-96.


The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance.

Cilloni D, Messa F, Arruga F, Defilippi I, Morotti A, Messa E, Carturan S, Giugliano E, Pautasso M, Bracco E, Rosso V, Sen A, Martinelli G, Baccarani M, Saglio G.

Leukemia. 2006 Jan;20(1):61-7.


Myelodysplastic syndromes.

Cilloni D, Messa F, Carturan S, Arruga F, Defilippi I, Messa E, Gottardi E, Saglio G.

Ann N Y Acad Sci. 2004 Dec;1028:400-8. Review.


Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.

Cilloni D, Messa F, Gottardi E, Fava M, Arruga F, Defilippi I, Carturan S, Messa E, Morotti A, Giugliano E, Rege-Cambrin G, Alberti D, Baccarani M, Saglio G.

Cancer. 2004 Sep 1;101(5):979-88.


Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients.

Cilloni D, Carturan S, Gottardi E, Messa F, Fava M, Defilippi I, Arruga F, Saglio G.

Blood. 2004 Mar 15;103(6):2428; author reply 2429. No abstract available.


Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.

Cilloni D, Carturan S, Gottardi E, Messa F, Messa E, Fava M, Diverio D, Guerrasio A, Lo-Coco F, Saglio G.

Blood. 2003 Oct 1;102(7):2705-6. No abstract available.


Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.

Cilloni D, Gottardi E, Fava M, Messa F, Carturan S, Busca A, Guerrasio A, Saglio G.

Blood. 2003 Jul 15;102(2):773-4; author reply 774. No abstract available.


Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, Levis A, Saglio G; Piedmont Study Group on Myleodysplastic Syndromes.

J Clin Oncol. 2003 May 15;21(10):1988-95.


Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.

Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, Rege-Cambrin G, Guerrasio A, Divona M, Lo Coco F, Saglio G.

Leukemia. 2002 Oct;16(10):2115-21.


[Acebutolol as monotherapy of essential arterial hypertension].

Mazzaferro S, Giuliano G, Lucchini M, Airoldi G, Finistauri D, Massimetti C, Messa F, Coen G.

Clin Ter. 1984 May 31;109(4):315-21. Italian. No abstract available.


1-alpha-OH-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: effects on renal function and on secondary hyperparathyroidism.

Coen G, Messa F, Massimetti C, Mazzaferro S, Manganiello M, Donato G, Finistauri D, Giuliano G, Cinotti GA.

Acta Vitaminol Enzymol. 1984;6(2):129-35.


Supplemental Content

Support Center